SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001193805-14-000059
Filing Date
2014-01-14
Accepted
2014-01-14 19:04:00
Documents
1
Period of Report
2013-09-12

Document Format Files

Seq Description Document Type Size
1 e611746_4a-shkreli.html 4/A  
1 e611746_4a-shkreli.xml 4/A 7904
  Complete submission text file 0001193805-14-000059.txt   9307
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Issuer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 0229
SIC: 2834 Pharmaceutical Preparations

Mailing Address 330 MADISON AVENUE, 6TH FLOOR NEW YORK NY 10017
Business Address
Shkreli Martin (Reporting) CIK: 0001525354 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36257 | Film No.: 14528414